Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
about
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor MicroenvironmentsGalectins and gliomas.The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase.Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children.Immune therapeutic targeting of glioma cancer stem cells.Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survivalNew roles for galectins in brain tumors--from prognostic markers to therapeutic targets.Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.Brain sweet brain: importance of sugars for the cerebral microenvironment and tumor development.Galectin-1 and immunotherapy for brain cancer.A biphasic tumor consisting of pilocytic astrocytoma with an anaplastic solitary fibrous tumor component in the pineal region: a case report and literature review.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Galectins and neovascularization in central nervous system tumors.Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activationGlioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Galectin-3: a useful biomarker for differential diagnosis of brain tumors.Glycosylation Changes in Brain Cancer.Increased β-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke.
P2860
Q26744513-4D4567DF-BED5-43BC-986E-9FDDDB74691EQ33588438-EA46EA16-4AE2-48ED-B3B5-7605146511ABQ34117467-28F204B3-5807-4901-A3F1-02A196DF5C9FQ34131307-B65697A3-66E5-46A0-8091-C928B4C68664Q34676437-26443124-527D-44BA-AF20-474034D23DC5Q35392528-A388B5AE-C409-4201-9A1F-A21507ACF5AEQ36136988-1281239F-C2AD-43D0-A151-4511E5EF98A0Q37225840-267FD507-3A10-4187-BEEE-03237F7E601CQ37806972-E5B9827E-F0BF-4AA8-A06B-2A7ECA04CCF3Q37862237-E433262C-900D-41F1-9447-954495224E29Q38043538-A68D0F36-63CC-4EA3-AF56-DB4DB7502347Q38165795-3EE19835-305D-469B-89A7-1A2985FB0A1DQ38214808-EC06DBA0-71A7-4CE7-AE27-4B34B53D81E4Q41472543-5284C149-7566-487F-833F-008E3D606603Q44293216-4CA6329E-EFDB-4376-8EA7-79C43ACC2D4FQ45113178-6BFD5009-D193-4603-A9F8-F93717AB26CEQ47691736-81229100-36A2-4247-8F59-54BCC8E55FBEQ48895485-6D2A4D0D-84D0-4A92-8887-8066EBB1BB5FQ49206188-D5E4E90C-E633-463A-B744-3B92A3DC0AD9
P2860
Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@en
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@nl
type
label
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@en
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@nl
prefLabel
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@en
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@nl
P2093
P2860
P1433
P1476
Galectin-3 as an immunohistoch ...... anaplastic oligodendrogliomas.
@en
P2093
Alberto Alain Gabbai
Benedicto Oscar Colli
Carlos Gilberto Carlotti
Flavio Miura
Luciano Neder
Marco A Zago
Miyuki Uno
Paulo Henrique Aguiar
Rodrigo Proto Siqueira
Roger Chammas
P2860
P304
P356
10.1111/J.1750-3639.2004.TB00083.X
P577
2004-10-01T00:00:00Z